In short
Doxorubicin Hydrochloride, a powerful chemotherapy drug, is being extensively studied in clinical trials for various types of cancer. These trials aim to evaluate its effectiveness, safety, and potential new applications when used alone or in combination with other treatments. The research spans different formulations and dosing regimens, seeking to optimize patient outcomes while minimizing side effects.
At a glance
- Cancer Types Studied
- Ovarian, breast, soft tissue sarcoma, epithelioid sarcoma, AIDS-related Kaposi sarcoma, multiple myeloma
- Administration Methods
- Intravenous infusion, often as liposomal formulation
- Common Dosages
- 50 mg/m2 every 28 days, 75 mg/m2 on day 1 of each cycle (up to 6 cycles)
- Primary Objectives
- Safety assessment, efficacy evaluation, pharmacokinetic analysis, bioequivalence studies
- Combination Therapies
- With bevacizumab, tazemetostat, and other anticancer agents
- Key Outcome Measures
- Progression-free survival, overall survival, response rates, adverse events
- Specific Monitoring
- Cardiotoxicity, left ventricular ejection fraction, hematological toxicities
- Trial Durations
- Typically several months to over a year, with long-term follow-up
What is Doxorubicin Hydrochloride?
Doxorubicin Hydrochloride, commonly known as doxorubicin, is a powerful chemotherapy drug used to treat various types of cancer. It belongs to a class of medications called anthracyclines. Doxorubicin is also known by several other names, including Adriamycin, hydroxydaunorubicin, and Rubex. These alternative names are important to know as your healthcare provider might use them interchangeably.
How Does Doxorubicin Work?
Doxorubicin works by interfering with the growth and spread of cancer cells in your body. It does this in several ways: It stops cancer cells from dividing and growing It damages the DNA in cancer cells, which can lead to cell death It may also affect the formation of new blood vessels that tumors need to grow By targeting rapidly dividing cells, doxorubicin can effectively slow down or stop the growth of tumors.
What Conditions Does Doxorubicin Treat?
Doxorubicin is used to treat a wide range of cancers. Based on the clinical trials information provided, it has been studied for use in: Soft Tissue Sarcoma: A type of cancer that develops in soft tissues like muscles, tendons, and blood vessels Ovarian Cancer: Cancer that begins in the ovaries Kidney Cancer: Including advanced or metastatic renal cell carcinoma Urothelial Cancer: Cancer that affects the urinary system, including the bladder Breast Cancer: Particularly in cases of triple-negative breast cancer Prostate Cancer: Especially in cases that don't respond to hormone therapy It's important to note that doxorubicin may be used for other types of cancer as well, depending on your specific diagnosis and treatment plan.
How is Doxorubicin Administered?
Doxorubicin is typically given as an intravenous (IV) injection or infusion. This means it's delivered directly into your bloodstream through a vein. The dosage and frequency of administration can vary depending on several factors, including: The type and stage of cancer being treated Your body size (often calculated as body surface area) Your overall health and how well you tolerate the medication In some of the clinical trials, doxorubicin was administered in the following ways: 75 mg/m² IV on day 1 of each 21-day cycle 24 mg/m² IV weekly for 12 weeks Your healthcare team will determine the most appropriate dosing schedule for your specific situation.
Doxorubicin in Combination Therapy
Doxorubicin is often used in combination with other cancer treatments to enhance its effectiveness. Some combinations being studied include: Doxorubicin + L19TNF: For advanced soft tissue sarcoma Doxorubicin + Ixazomib + Gemcitabine: For kidney cancer and urothelial cancer Doxorubicin + Pembrolizumab: For advanced sarcomas Doxorubicin + Tazemetostat: For advanced epithelioid sarcoma Doxorubicin + Cyclophosphamide + Paclitaxel + Carboplatin: For breast cancer Doxorubicin + Estramustine: For prostate cancer These combinations are designed to target cancer cells in multiple ways, potentially improving treatment outcomes.
Potential Side Effects
Like all chemotherapy drugs, doxorubicin can cause side effects. Common side effects may include: Nausea and vomiting Hair loss Fatigue Increased risk of infections Mouth sores One important potential side effect to be aware of is heart damage. Doxorubicin can affect heart function, especially at higher cumulative doses. Your doctor will monitor your heart health closely during treatment. It's crucial to report any side effects you experience to your healthcare team. They can help manage these effects and may adjust your treatment if necessary.
Ongoing Research and Clinical Trials
Researchers are continually studying doxorubicin to find new ways to use it more effectively and safely. Some areas of ongoing research include: New drug combinations: Combining doxorubicin with newer drugs like pembrolizumab (an immunotherapy drug) or tazemetostat (a targeted therapy) Different dosing schedules: Such as "metronomic" dosing, which involves giving smaller doses more frequently Use in specific cancer types: For example, studying its effectiveness in triple-negative breast cancer or advanced epithelioid sarcoma These ongoing studies aim to improve treatment outcomes and reduce side effects for patients receiving doxorubicin.